Publication Date:
2013-04-04
Description:
Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy British Journal of Cancer 108, 1316 (2 April 2013). doi:10.1038/bjc.2013.79 Authors: J M Jürgensmeier, H-J Schmoll, J D Robertson, L Brooks, M Taboada, S R Morgan, D Wilson & P M Hoff
Keywords:
colorectalcediranibbevacizumabVEGFbiomarkers
Print ISSN:
0007-0920
Electronic ISSN:
1532-1827
Topics:
Medicine
Permalink